New tool helps identify anxiety and depression in pediatric surgery patients

Rapt Ther­a­peu­tics said it will close and un­blind two mid-stage tri­als in atopic der­mati­tis and asth­ma af­ter they were put on clin­i­cal hold ear­li­er this

The FDA on Tues­day cleared Mer­ck’s pul­monary ar­te­r­i­al hy­per­ten­sion treat­ment, which could quick­ly be­come a block­buster for the New Jer­sey phar­ma gi­ant. Mer­ck will mar­ket